Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MAT.0000000000001251 http://scihub22266oqcxt.onion/10.1097/MAT.0000000000001251 33136589!ä!33136589 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       ASAIO+J 2020 ; 66 (10): 1069-1072 Nephropedia Template TP {{tp|p=33136589|t=2020. Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic |pdf=|usr=}}{{33136589}} gab.com Text Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic JO: ASAIO J http://www.kidney.de/pget.php?&tw=1&pmid=33136589 #FOAvip Extracorporeal membrane oxygenation (ECMO) is recognized as organ support for potentially reversible acute respiratory distress syndrome (ARDS). However, limited resource during the outbreak and the coagulopathy associated with coronavirus disease 2019 (COVID-19) make the utilization of venovenous (VV) ECMO highly challenging. We herein report specific considerations for cannulation configurations and ECMO management during the pandemic. High blood flow and anticoagulation at higher levels than usual practice for VV ECMO may be required because of thrombotic hematologic profile of COVID-19. Among our first 24 cases (48.8 +/- 8.9 years), 17 patients were weaned from ECMO after a mean duration of 19.0 +/- 10.1 days and 16 of them have been discharged from ICU. Twit Text FOAVip Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic ????ASAIO J http://www.kidney.de/pget.php?&tw=1&pmid=33136589 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33136589 #FOAvip English Wikipedia <ref>{{Cite pmid|33136589}}</ref> Specific Considerations for Venovenous Extracorporeal Membrane Oxygenation During Coronavirus Disease 2019 Pandemic #MMPMID33136589 Guihaire J; Owyang CG; Madhok J; Laverdure F; Gaillard M; Girault A; Lebreton G; Mercier O ASAIO J 2020[Nov]; 66 (10): 1069-1072 PMID33136589show ga Extracorporeal membrane oxygenation (ECMO) is recognized as organ support for potentially reversible acute respiratory distress syndrome (ARDS). However, limited resource during the outbreak and the coagulopathy associated with coronavirus disease 2019 (COVID-19) make the utilization of venovenous (VV) ECMO highly challenging. We herein report specific considerations for cannulation configurations and ECMO management during the pandemic. High blood flow and anticoagulation at higher levels than usual practice for VV ECMO may be required because of thrombotic hematologic profile of COVID-19. Among our first 24 cases (48.8 +/- 8.9 years), 17 patients were weaned from ECMO after a mean duration of 19.0 +/- 10.1 days and 16 of them have been discharged from ICU. |Anticoagulants/therapeutic use[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/complications/*therapy[MESH] |Extracorporeal Membrane Oxygenation/adverse effects/*methods[MESH] |Female[MESH] |Heparin/therapeutic use[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Pneumonia, Viral/complications/*therapy[MESH] |Respiratory Distress Syndrome/virology[MESH] |SARS-CoV-2[MESH]Specific Considerations for Venovenous Extracorporeal Membrane Oxygena(epmc).pdf DeepDyve Pubget Overpricing